Compound Summary


  Compound Information
 (-)-Rapamycin

Compound Name:

(-)-Rapamycin

Compound CID:

5284616

Synonyms:

(-)-Rapamycin

53123-88-9

AY 22989

AY-22989

I 2190A

More...

Iupac Name:

(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-[(2R)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone

InChI:

InChI=1S/C51H79NO13/c1-30-16-12-11-13-17-31(2)42(61-8)28-38-21-19-36(7)51(60,65-38)48(57)49(58)52-23-15-14-18-39(52)50(59)64-43(33(4)26-37-20-22-40(53)44(27-37)62-9)29-41(54)32(3)25-35(6)46(56)47(63-10)45(55)34(5)24-30/h11-13,16-17,25,30,32-34,36-40,42-44,46-47,53,56,60H,14-15,18-24,26-29H2,1-10H3/b13-11+,16-12+,31-17+,35-25+/t30-,32-,33-,34-,36-,37+,38+,39+,40-,42+,43+,44-,46-,47+,51-/m1/s1

InChIKey:

QFJCIRLUMZQUOT-HPLJOQBZSA-N

Canonical Smiles:

CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC

Isomeric Smiles:

C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC

Molecular Weight:

914.2

Molecular Formula:

C51H79NO13

  Compound Structure
 2D Structure:
 3D Structure:
  Computed Properties
 (-)-Rapamycin

Molecular Weight:

914.2

Molecular Formula:

C51H79NO13

Hydrogen Bond Donor Count:

3

Hydrogen Bond Acceptor Count:

13

Rotatable Bond Count:

6

Heavy Atom Count:

65

Complexity:

1760

  Synonyms
 (-)-Rapamycin

(-)-Rapamycin (-)-Rapamycin

(-)-Rapamycin

53123-88-9

AY 22989

AY-22989

I 2190A

I-2190A

I2190A

NSC 226080

RAPA

Rapammune

Rapamune

Rapamycin

SIIA 9268A

Sirolimus

Wy 090217

Rapamycin (Sirolimus)

Antibiotic AY 22989

UNII-W36ZG6FT64

CHEBI:9168

W36ZG6FT64

WY-090217

DE-109

MFCD00867594

NCGC00021305-05

DSSTox_CID_3582

sirolimusum

DSSTox_RID_77091

DSSTox_GSID_23582

SILA 9268A

Supralimus

C51H79NO13

(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-{(2S)-1-(1S,3R,4R)-4-hydroxy-3-methoxycyclohexylpropan-2-yl}-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo30.3.1.0(4,9)hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone

(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-(1S,3R,4R)-4-hydroxy-3-methoxycyclohexylpropan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido2,1-c1,4oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone

CAS-53123-88-9

Perceiva

Cypher

CCRIS 9024

NSC226080

HSDB 7284

1fkb

1pbk

NSC-226080

NCGC00181146-01

LCP-Siro

(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone

(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(1R)-2-(1S,3R,4R)-4-hydroxy-3-(methyloxy)cyclohexyl-1-methylethyl}-6,8,12,14,20,26-hexamethyl-10,21-bis(methyloxy)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido2,1-c1,4oxazacyclohentriacontine-1,5,11,28,29(6H,31H)-pentone

RAP

S1039

BiomolKI2_000084

Rapamycin C-7, analog 4

SCHEMBL3463

Rapamycin,Sirolimus,Rapamune

BIDD:PXR0165

23,27-Epoxy-3H-pyrido2,1-c1,4oxaazacyclohentriacontine

MLS006010168

Sirolimus USAN:INN:BAN

GTPL6031

DTXSID5023582

BDBM36609

L04AA10

MS-R001

SYN1185

SM-88 COMPONENT SIROLIMUS

HMS2089A21

HMS3403F11

HMS3884C03

(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-(1R)-2-(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl-1-methylethyl-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido2,1-c1,4oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone

EX-A1044

Tox21_110870

Tox21_112750

AC-722

BDBM50064359

STL570275

AKOS015850976

AKOS015961618

ZINC169289388

ACN-035837

CCG-100684

CS-0063

DB00877

NSC-2260804

NCGC00021305-06

NCGC00021305-07

Rapamycin from Streptomyces hygroscopicus

AS-11687

HY-10219

SMR004701276

UNM-0000358684

A-275

R0097

Rapamycin, RAPA, Rapamune, Sirolimus, RPM

Rapamycin, VETRANAL(TM), analytical standard

EC 610-965-5

M02444

Q32089

123R889

Q-201659

BRD-K84937637-001-04-0

BRD-K84937637-001-06-5

BRD-K89626439-001-01-0

24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypy

Rapamycin from Streptomyces hygroscopicus, >=95% (HPLC), powder

Rapamycin from Streptomyces hygroscopicus, Vetec(TM) reagent grade, >=95%

Sirolimus solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material

(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-{(2S)-1-(1S,3R,4R)-4-hydroxy-3-methoxycyclohexylpropan-2-yl}-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo30.3.1.04,9hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone

(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34 aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hex adecahydro-9,27-dihydroxy-3-(1R)-2-(1S,3R,4R)-4-hydro xy-3-methoxycyclohexyl-1-methylethyl-10,21-dimethoxy- 6,8,12,14,20,26-hexamethyl-23,27-ep

(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-4,9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-heptadecahydro-9,27-dihydroxy-3-(1R)-2-(1S,3,4R)-4-hydroxy-3-methoxycyclohexyl-1-methylethyl-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-223,27-Epoxy-3H-pyrido2,1-c1,4oxaazacyclohentriacontine-1,5,11,28,29(6H,31H)-pentone

(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(1R)-2-(1S,3R,4R)-4-hydroxy-3-(methyloxy)cyclohexyl-1-methylethyl}-6,8,12,14,20,26-hexamethyl-10,21-bis(methyloxy)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro

(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(1R)-2-(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl-1-methylethyl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido2,1-c1,4oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone

(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{1-(1S,3R,4R)-4-hydroxy-3-methoxycyclohexylpropan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,

1,18-Dihydroxy-12-2-(4-hydroxy-3-methoxy-cyclohexyl)-1-methyl-ethyl-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-aza-tricyclo30.3.1.0*4,9*hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone (Rapamycin)

  Experimental Data
 (-)-Rapamycin

Species Dosage Unit CG Lifespan(AVG/MED days) TG Lifespan(AVG/MED days) Lifespan Change(AVG/MED%) CG Lifespan(MAX days) TG Lifespan(MAX days) Lifespan Change(MAX%) Significant Strain Gender PubMed Active Label
Caenorhabditis elegans 50 umol/L 12.15 S N2 30970250 Active
Caenorhabditis elegans 50 umol/L 16.14 S N2 30970250 Active
Mus musculus 4 mg/kg 0 S C57BL/6J MALES 19934433 Active
Mus musculus 2.24 mg/kg 1094 1245 14 Unclear ALL SITES FEMALES 19587680
Saccharomyces cerevisiae 0.55 nM Unclear 18513215
Caenorhabditis elegans 1 ug/mL Unclear N2 33683565
Mus musculus 2.24 mg/kg 1078 1179 9 Unclear ALL SITES MALES 19587680
Mus musculus 8 mg/kg 925 1054 14 S C57BL/6JNia MALES 27549339 Active
Mus musculus 14 ppm 14 16 S C57BL/6J FEMALES 24409289 Active
Drosophila melanogaster 200 umol/L 95 100 0.05 Unclear yw FEMALES 20074526
Mus musculus 2.24 mg/kg 5 1035 1142 10 Unclear TJL MALES 19587680
Mus musculus 14 ppm 7 11 S C57BL/6J MALES 24409289 Active
Drosophila melanogaster 200 umol/L 92 100 0.09 Unclear WDAB FEMALES 20074526
Mus musculus 8 mg/kg 231 372 61 S C57BL/6JNia MALES 27549339 Active
Mus musculus 2.24 mg/kg 16 1094 1250 14 Unclear UM FEMALES 19587680
Mus musculus 2.24 mg/kg 7 1089 1179 8 Unclear UT FEMALES 19587680
Caenorhabditis elegans 10 umol/L 23.14 27.64 18.93 S N2 26676933 Active
Drosophila melanogaster 200 umol/L 78 81 0.04 Unclear WDAB FEMALES 20074526
Mus musculus 2.24 mg/kg 15 1100 1282 17 Unclear TJL FEMALES 19587680
Mus musculus 8 mg/kg 188 231 22 S C57BL/6JNia 27549339 Active
Mus musculus 4.7 mg/kg 896 1043 16 1159 1218 5 S UM-HET3 FEMALES 24341993 Active
Caenorhabditis elegans 400 umol/L 13.5 15 0.11 21.5 26 0.21 S N2 34091442 Active
Caenorhabditis elegans 100 umol/L 21.89 25.94 19 S N2 22560223 Active
Drosophila melanogaster 20 umol/L 52.83 55.1 4.29 NS FEMALES 33008901 Inactive
Caenorhabditis elegans 100 umol/L 24.05 32.66 36 S N2 22560223 Active
Caenorhabditis elegans 100 umol/L 23.55 28.89 23 S N2 22560223 Active
Mus musculus 8 mg/kg 161 161 0 NS C57BL/6JNia FEMALES 27549339 Inactive
Drosophila melanogaster 10 umol/L 62.4 70.5 13 S w1118 FEMALES 28025308 Active
Mus musculus 42 mg/kg 807 992 23 1094 1185 8 S UM-HET3 MALES 24341993 Active
Caenorhabditis elegans 2 nM 18.92 20.68 0.09 S N2 34771018 Active
Drosophila melanogaster 0.005 mM 14 4.7 S Canton-S 24096697 Active
Mus musculus 2 mg/kg 859.9 972 13 897 960 7 S C57BL/6JNia FEMALES 27091134 Active
Mus musculus 42 mg/kg 896 1132 26 1159 1282 11 S UM-HET3 FEMALES 24341993 Active
Mus musculus 14 mg/kg 807 909 13 1094 1180 8 S UM-HET3 MALES 24341993 Active
Caenorhabditis elegans 100 umol/L 15.47 18.76 21 S N2 29874838 Active
Caenorhabditis elegans 1 nM 21.9 25.3 0.16 Unclear 23698443
Drosophila melanogaster 5 umol/L 62.4 72.6 16.4 S w1118 FEMALES 28025308 Active
Drosophila melanogaster 200 umol/L 47.16 38.86 -17.6 NS MALES 33008901 Inactive
Mus musculus 2.24 mg/kg 8 1141 1188 4 Unclear UM MALES 19587680
Mus musculus 1.5 mg/kg 10.1 9.3 S 129/Sv FEMALES 22107964 Active
Caenorhabditis elegans 10 umol/L 18.93 S N2 33683565 Active
Mus musculus 8 mg/kg 847 847 0 NS C57BL/6JNia FEMALES 27549339 Inactive
Mus musculus 14 mg/kg 896 1086 21 1159 1285 11 S UM-HET3 FEMALES 24341993 Active
Caenorhabditis elegans 100 umol/L 23.36 26.33 13 S N2 22560223 Active
Mus musculus 4.7 mg/kg 807 834 3 1094 1162 6 NS UM-HET3 MALES 24341993 Inactive
Caenorhabditis elegans 100 umol/L 26 21 31 0.48 S N2 24332851 Active
Drosophila melanogaster 0.005 mM 12 4.8 S Canton-S 24096697 Active
Mus musculus 2.24 mg/kg 15 1020 1179 16 Unclear UT MALES 19587680
Drosophila melanogaster 200 umol/L 86 96 0.12 Unclear w1118 FEMALES 20074526
Drosophila melanogaster 0.5 umol/L 34 36 0.06 48 74 0.54 S Canton-S FEMALES 20017609 Active
Drosophila melanogaster 0.5 umol/L 37 39 0.05 71 46 -0.35 S Canton-S MALES 20017609 Active
  Experimental Data Visualization
 (-)-Rapamycin

  Statistics Data
 (-)-Rapamycin

Species Lifespan Change(AVG/MED%) Lifespan Change(MAX%) Count Reference Count Data point
Caenorhabditis elegans 36 0.48 9 14
Drosophila melanogaster 16.4 4.8 5 12
Mus musculus 61 17 7 24
Saccharomyces cerevisiae 1 1
  Statistics Data Visualization
 (-)-Rapamycin